As of 2025-09-16, the Relative Valuation of Dechra Pharmaceuticals PLC (DPH.L) is (493.19) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 3,866.00 GBP, the upside of Dechra Pharmaceuticals PLC based on Relative Valuation is -112.8%.
The range of the Relative Valuation is (414.16) - (591.10) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.5x - 24.1x | 19.8x |
| Forward P/E multiples | 16.9x - 24.7x | 20.4x |
| Fair Price | (414.16) - (591.10) | (493.19) |
| Upside | -110.7% - -115.3% | -112.8% |
| Date | P/E |